Predictors of weight loss and maintenance during 2 years of treatment by sibutramine in obesity. Results from the European multi-centre STORM trial-Reference-Cited by-同舟云学术

Predictors of weight loss and maintenance during 2 years of treatment by sibutramine in obesity. Results from the European multi-centre STORM trial

Published:2001-04 Issue:4 Volume:25 Page:496-501
ISSN:0307-0565
Container-title:International Journal of Obesity
language:en
Short-container-title:Int J Obes

Author:

Hansen DL, ,Astrup A,Toubro S,Finer N,Kopelman P,Hilsted J,Rössner S,Saris WHM,Van Gaal LF,James WPT,Goulder M

Publisher

Springer Science and Business Media LLC

Subject

Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Medicine (miscellaneous)

Link

http://www.nature.com/articles/0801481.pdf

Reference19 articles.

1. Astrup A, Buemann B, Gluud C, Bennett P, Tjur T, Christensen NJ . Prognostic markers for diet-induced weight loss in obese women Int J Obes Relat Metab Disord 1995 19: 275–278.

2. Bild DE, Sholinsky P, Smith DE, Lewis CE, Hardin JM, Burke GI . Correlates and predictors of weight loss in young adults: the CARDIA study. Int J Obes Relat Metab Disord 1996 20: 47–55.

3. Bray GA, Ryan DH, Gordon D, Heidingsfelder S, Cerise F, Wilson K . A double-blind randomized placebo-controlled trial of sibutramine. Obes Res Relat Metab Disord 1996 4: 263–270.

4. Froidevaux F, Schutz Y, Christin L, Jequier E . Energy expenditure in obese vomen before and during weight loss, after refeeding, and in weight-relapse period Am J Clin Nutr 1993 57: 35–42.

5. Grundlah C, Heal DJ, Auerbach SB . In vivo criteria to differentiate monoamine reuptake inhibitors from releasing agents: sibutramine is a reuptake inhibitor J Pharmac Exp Ther 1997 283: 581–591.

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differential mechanisms affecting weight loss and weight loss maintenance;Nature Metabolism;2023-08-23

2. A meta-analysis comparing short-term weight and cardiometabolic changes between olanzapine/samidorphan and olanzapine;Scientific Reports;2021-04-07

3. Describing the Weight‐Reduced State: Physiology, Behavior, and Interventions;Obesity;2021-03-23

4. Platform introducing individually tailored variability in nerve stimulations and dietary regimen to prevent weight regain following weight loss in patients with obesity;Obesity Research & Clinical Practice;2021-03

5. Percutaneous CT-Guided Cryovagotomy;Techniques in Vascular and Interventional Radiology;2020-03